Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
---|---|---|---|---|---|
1 | Bladder cancer 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
2 | Bladder cancer 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [5] 51, 85, 89, 227, 228 💬
|
3 | Calcium signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
4 | Calcium signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [5] 51, 85, 89, 227, 228 💬
|
5 | Central carbon metabolism in cancer 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
6 | Central carbon metabolism in cancer 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [5] 51, 85, 89, 227, 228 💬
|
7 | EGFR tyrosine kinase inhibitor resistance 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
8 | EGFR tyrosine kinase inhibitor resistance 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [5] 51, 85, 89, 227, 228 💬
|
9 | Endocytosis 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
10 | Endocytosis 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [5] 51, 85, 89, 227, 228 💬
|
11 | MAPK signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
12 | MAPK signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [5] 51, 85, 89, 227, 228 💬
|
13 | MicroRNAs in cancer 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
14 | MicroRNAs in cancer 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [5] 51, 85, 89, 227, 228 💬
|
15 | Pathways in cancer 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
16 | Pathways in cancer 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [5] 51, 85, 89, 227, 228 💬
|
17 | PI3K-Akt signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
18 | PI3K-Akt signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [5] 51, 85, 89, 227, 228 💬
|
19 | Rap1 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
20 | Rap1 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [5] 51, 85, 89, 227, 228 💬
|
21 | Ras signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
22 | Ras signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [5] 51, 85, 89, 227, 228 💬
|
23 | Regulation of actin cytoskeleton 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
24 | Regulation of actin cytoskeleton 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [5] 51, 85, 89, 227, 228 💬
|
25 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
26 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 2 drugs (DrugBank) and 6 diseases |
FGFR3 [1] FGFR3 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [5] 51, 85, 89, 227, 228 💬
|